Lexaria Bioscience Corp. - Common Stock (NQ:LEXX)
0.9000
+0.0448
(+5.24%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
All News about Lexaria Bioscience Corp. - Common Stock

Via ACCESSWIRE


Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
November 25, 2024
Via ACCESSWIRE

Lexaria Signs Contract For New DehydraTECH GLP-1 Biodistribution Study
November 14, 2024
Via ACCESSWIRE


Lexaria Updates Fast-Moving GLP-1 'Arm's Race' Developments
November 07, 2024
Via ACCESSWIRE




Lexaria's GLP-1 Human Pilot Study #3 Begins Dosing
October 09, 2024
Via ACCESSWIRE

Via ACCESSWIRE



Lexaria Updates Current GLP-1 Market
October 08, 2024
Via ACCESSWIRE

Lexaria Appoints Michael Shankman as Chief Financial Officer
October 01, 2024
Via ACCESSWIRE
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free